Brown Advisory’s CalciMedica CALC Stock Holding History

Brown Advisory’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-776	Closed	-$5.43K	–	1213
2022 Q4	$5.43K	Sell	776 -534	-41%	-$5.99K	﹤0.01%	1201
2022 Q3	$17K	Buy	1,310 +89	+7%	+$1.26K	﹤0.01%	1125
2022 Q2	$18K	Sell	1,221 -215	-15%	-$2.94K	﹤0.01%	1096
2022 Q1	$25K	Buy	1,436 +445	+45%	+$8.48K	﹤0.01%	1102
2021 Q4	$25K	Hold	991	–	–	﹤0.01%	1231
2021 Q3	$46K	Sell	991 -176	-15%	-$9.9K	﹤0.01%	1094
2021 Q2	$88K	Sell	1,167 -819	-41%	-$53.7K	﹤0.01%	1053
2021 Q1	$154K	Buy	+1,986	New	+$594K	﹤0.01%	1044

Brown Advisory's CALC Position: Q1 2023 in Review

Brown Advisory sold out of CalciMedica (CALC) in Q1 2023, closing a stake of 776 shares — an estimated $5.43K sold.

Brown Advisory first reported a position in CALC in Q1 2021 and held it in 8 quarters. The position peaked at $154K in Q1 2021. 0 funds tracked by Wall St. Rank hold CALC as of Q1 2023.

Brown Advisory reported no remaining CalciMedica position as of Q1 2023 after selling out during the quarter.
Brown Advisory sold 776 CalciMedica shares in Q1 2023, an estimated $5.43K.
Brown Advisory first reported a position in CalciMedica in Q1 2021 and held it in 8 quarters.
Brown Advisory's CalciMedica position peaked at $154K in Q1 2021.
0 funds tracked by Wall St. Rank held CalciMedica as of Q1 2023.

Based on Brown Advisory's 13F filing for Q1 2023, filed 8 May 2023.